Aidence
- Company typePrivate
- Founded2015
- HeadquartersAmsterdam, Netherlands
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Aidence firmographics
Firmographics- Name
- Aidence
- Legal name
- Aidence
- Website
- https://aidence.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Aidence industry classification
Industry- Product category
- AI Radiology Software
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Medical Imaging AI (HDAAAEAH)
- akta.pro secondary industries
- AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)
Keywords
Where Aidence is headquartered
LocationHeadquarters
- HQ city
- Amsterdam
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Aidence business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Software Subscription: The company provides AI-powered clinical applications for the lung cancer pathway on a subscription basis to healthcare providers, hospitals, and radiology departments across Europe and the UK NHS.
Distribution channels1 record
Marketing channels7 records
Aidence product offering
Product offeringCore offering
Aidence develops AI-powered clinical applications for the lung cancer pathway. Its flagship product, Veye Lung Nodules, is a CE-certified deep learning solution that automatically detects, quantifies, and tracks pulmonary nodules on chest CT scans, integrating directly into the radiology PACS workflow. Veye Reporting provides standardised, customisable reports for lung cancer screening programmes. The company now operates as part of DeepHealth (subsidiary of RadNet).
Product overview
Aidence offers a unified AI-powered clinical application portfolio for the lung cancer pathway. The core product is Veye Lung Nodules, a CE-certified deep learning solution for automated pulmonary nodule detection and quantification on chest CT scans. This integrates directly into the radiology PACS workflow. Veye Reporting is the companion module for standardised quality reporting in lung cancer screening programmes, presenting Veye Lung Nodules results in shareable report format. The company is now part of DeepHealth (subsidiary of RadNet) and focuses exclusively on lung cancer diagnostics, with NHS deployment in the UK's Targeted Lung Health Checks programme.
Differentiator
Problem solved
Functional benefit
Brands
- Veye Lung Nodules: CE certified AI solution for automated lung nodule detection and quantification on chest CTs, suitable for routine clinical practice and lung cancer screening.
- Veye Reporting
Products and services
- Veye Lung Nodules CE-certified AI solution for automated lung nodule detection and quantification on chest CT scans. Functions as a second or concurrent reader, detecting solid and sub-solid nodules 3-30mm, providing diameter and volume measurements, growth tracking with volume doubling time, and integrating directly into the radiology PACS workflow. Deployed in hospitals across Europe and UK NHS.
- Veye Reporting Interactive lung nodule reporting solution for standardised quality reporting in lung cancer screening programmes. Presents Veye Lung Nodules results in a clear, customisable and shareable report format for radiology departments and screening programme operators.
Quantifiable outcome
- 91% sensitivity at 1 false positive per scan
- +2 more outcomes
Companies that use Aidence
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
Aidence technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability2 records
Feature3 records
Aidence partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core, major and minor.
- DeepHealthcoreDeepHealth is listed as a partner. DeepHealth is a subsidiary of RadNet and provides AI-powered imaging informatics solutions. Aidence notes on their homepage that 'Aidence is now DeepHealth', indicating an acquisition or merger relationship.
- RadNetcoreRadNet is listed as a partner. DeepHealth is a subsidiary of RadNet, indicating strategic alignment in AI-powered radiology solutions.
- ThironamajorThirona is a research partner. Aidence, Incepto, and Thirona launched a joint clinical solution to support the expansion of lung cancer screening in Europe.
- AstraZenecamajorVeye was handpicked by AstraZeneca for the European PINPOINT project, aiming to increase early lung cancer diagnosis through better detection and follow-up of incidental pulmonary nodules. Also mentioned in ongoing projects section.
- InceptomajorIncepto is listed as a partner. Aidence, Incepto, and Thirona launched a joint clinical solution to support the expansion of lung cancer screening in Europe.
- 4 Ways Diagnosticsminor4 Ways Diagnostics is listed as a market partner, UK-based diagnostic imaging provider.
- Alliance MedicalminorAlliance Medical is listed as a market partner, UK-based diagnostic imaging provider.
- AffideaminorAffidea is listed as a market partner, European healthcare provider.
- TMC (Telemedicine Clinic)minorTMC is listed as a market partner for radiology services.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Aidence competitors and assessment
Company assessmentDirect peers
- Thirona: Thirona develops AI-based lung image analysis software for CT scans, including nodule detection and quantification. They are a research partner of Aidence and jointly launched a lung cancer screening solution in Europe — making them both a close peer and collaborator.
- Incepto: Incepto is a European AI radiology platform that distributes and co-develops clinical AI applications, including lung cancer screening solutions alongside Aidence and Thirona. Comparable as a European radiology AI distribution and co-development platform.
- Optellum: Optellum is an AI platform specifically focused on lung cancer early detection and diagnosis, including lung nodule characterization on CT. Direct overlap with Aidence's Veye Lung Nodules in clinical use case and customer segment.
- Quibim: Quibim provides AI-powered medical imaging analysis tools across multiple imaging modalities, with a presence in European hospital networks. Comparable as a European radiology AI vendor competing for similar hospital AI budgets.
- ScreenPoint Medical: ScreenPoint Medical develops AI for breast and other imaging analysis, with a listed integration partnership with Aidence. Comparable as a medical imaging AI vendor operating in the European hospital market.
Emerging players
- Aidoc: Aidoc offers a broad suite of AI solutions for radiology workflows including chest CT analysis. While broader in scope than Aidence, they compete for the same hospital AI procurement budgets and workflow integration mindshare.
- Viz.ai: Viz.ai provides AI-powered clinical workflow tools across radiology, including chest imaging. Comparable as a radiology AI workflow vendor serving hospital systems, though with broader product scope than Aidence's lung focus.
- Annalise.ai: Annalise.ai offers comprehensive AI-driven radiology decision-support tools covering chest X-ray and CT, with European and global deployment. Overlaps with Aidence on chest CT analysis and European hospital customers.
Broad incumbents
- DeepHealth (RadNet subsidiary): DeepHealth is RadNet's AI-powered health informatics platform that now owns Aidence. As the parent, it is the closest broad incumbent context — operating a portfolio of imaging AI tools across multiple specialties and customer segments.
- Siemens Healthineers (AI-Rad Companion): Siemens Healthineers offers AI-Rad Companion, a broad radiology AI suite embedded in its imaging equipment and PACS environment. Comparable as a large incumbent offering lung/chest AI capabilities as part of a wider imaging portfolio.
Market position
Strengths3 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Aidence social profiles
Digital presenceAidence compliance and trust
Trust signalCompliance4 records
Aidence financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aidence leadership team
Management profileNumber of profiles
Profiles5 records
Aidence funding detail
Funding detailFunding overview
Funding rounds3 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aidence M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aidence
What does Aidence do?
Aidence develops AI-powered clinical applications for the lung cancer pathway. Its flagship product, Veye Lung Nodules, is a CE-certified deep learning solution that automatically detects, quantifies, and tracks pulmonary nodules on chest CT scans, integrating directly into the radiology PACS workflow. Veye Reporting provides standardised, customisable reports for lung cancer screening programmes. The company now operates as part of DeepHealth (subsidiary of RadNet).
Is Aidence a public or private company?
Aidence is a private company. It is classified as corporate owned and is currently operating.
When was Aidence founded?
Aidence was founded in 2015. It employs 11 to 50 people.
Where is Aidence based?
Aidence is headquartered in Amsterdam, Netherlands, in the Europe region.
How does Aidence make money?
One revenue line is on record: software Subscription.
Who are Aidence's main competitors?
Direct peers on record are Thirona, Incepto, Optellum, Quibim and ScreenPoint Medical. Emerging players are Aidoc, Viz.ai and Annalise.ai. Broad incumbents are DeepHealth (RadNet subsidiary) and Siemens Healthineers (AI-Rad Companion).
Does Aidence have an API?
No public API is recorded for Aidence.
What industry is Aidence in?
Aidence's product category is AI Radiology Software. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 54151 and its SIC code is 3841.